ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,740Medicare Part D Prescriptions Filled, Including Refills

Rank: 394 out of 2061

$788K Total Retail Price of All Prescriptions

Rank: 247 out of 2061

599 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 10,150 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 529 517 1 3
SIMVASTATIN 464 448 2 1
LISINOPRIL 459 449 3 2
OMEPRAZOLE 321 316 4 5
AMLODIPINE BESYLATE 314 306 5 4
ZOLPIDEM TARTRATE 263 261 6 23
TRAMADOL HCL 259 257 7 18
ATORVASTATIN CALCIUM 239 229 8 8
PRAVASTATIN SODIUM 213 198 9 14
LOSARTAN POTASSIUM 189 181 10 17
METOPROLOL SUCCINATE 178 176 11 19
HYDROCODONE-ACETAMINOPHEN 176 143 S3 12 10
METFORMIN HCL ER 162 155 13 71
FUROSEMIDE 158 148 14 6
HYDROCHLOROTHIAZIDE 140 135 15 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 139 134 16 27
NEXIUM 133 106 17 26
ATENOLOL 133 132 17 13
METOPROLOL TARTRATE 129 123 19 7
ALENDRONATE SODIUM 124 124 20 25
FLUTICASONE PROPIONATE 124 124 20 43
TAMSULOSIN HCL 106 101 22 30
SERTRALINE HCL 105 97 23 21
AZITHROMYCIN 104 99 24 34
GABAPENTIN 102 95 25 15
DONEPEZIL HCL 94 94 26 24
ADVAIR DISKUS 93 81 27 57
CITALOPRAM HBR 93 72 27 20
CARVEDILOL 88 78 29 22
CRESTOR 86 81 30 31
SYNTHROID 85 85 31 58
LOVASTATIN 84 81 32 35
METFORMIN HCL 75 75 33 9
POTASSIUM CHLORIDE 75 75 33 16
FLUOXETINE HCL 74 74 35 73
WARFARIN SODIUM 73 69 36 11
LOSARTAN-HYDROCHLOROTHIAZIDE 71 66 37 50
MELOXICAM 71 59 37 44
ALLOPURINOL 71 69 37 28
DOXAZOSIN MESYLATE 65 65 40 81
KLOR-CON M20 65 65 40 47
CIPROFLOXACIN HCL 62 59 42 54
CLONAZEPAM 62 62 42 241
GLIPIZIDE ER 61 58 44 133
JANUVIA 61 60 44 51
PREDNISONE 60 58 46 32
ZOSTAVAX 59 57 47 171
TRAZODONE HCL 58 54 48 39
CLOPIDOGREL 57 57 49 29
FENOFIBRATE 54 51 50 65
LANTUS 51 41 51 48
OXYBUTYNIN CHLORIDE ER 51 50 51 80
PAROXETINE HCL 51 51 51 61
FENTANYL 50 50 S2 54 84
AMITRIPTYLINE HCL 50 41 R 54 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.